The purpose of the trial is to evaluate the efficacy of an 8 week treatment with once-daily 9 mg budesonide in patients with active ulcerative colitis
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
University of Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany
Rate of clinical remission at final/withdrawal visit
Clinical remission includes normalisation of stool frequency and absence of blood in stools
Time frame: 8 weeks treatment
Rate of endoscopic remission/improvement at final/withdrawal visit
Time frame: 8 weeks treatment
Number of stools / bloody stools per week
Time frame: 8 weeks treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.